← Back to catalogue
Non-Sterile Single Use Bowmann Lacrimal Sinus Probe Diam 1.3/1.4mm Fig. 3/4
EUDAMEDClass I (EU MDR)
Ref BTOB5122Ref BTOB5133
Identity
- Trade Name
- Non-Sterile Single Use Bowmann Lacrimal Sinus Probe Diam 1.3/1.4mm Fig. 3/4 EUDAMEDNon-Sterile Single Use Bowmann Lacrimal Sinus Probe Diam 1.5/1.6mm Fig. 5/6 EUDAMED
- Device Name
- Non-Sterile Single Use Bowmann Lacrimal Sinus Probe Diam 1.3/1.4mm Fig. 3/4 EUDAMEDNon-Sterile Single Use Bowmann Lacrimal Sinus Probe Diam 1.5/1.6mm Fig. 5/6 EUDAMED
- Model / Reference
- BTOB5122 EUDAMEDBTOB5133 EUDAMED
Identifiers
- Primary DI / UDI-DI
- +G075BTOB51220P EUDAMED+G075BTOB51330R EUDAMED
- Basic UDI-DI
- B-+G075BTOB51220P EUDAMEDB-+G075BTOB51330R EUDAMED
- EMDN Code
- K01020110 MINIMALLY INVASIVE SURGERY CANNULAS, SINGLE-USE EUDAMED
Classification
- Device Class
- Class I EUDAMED
- Market of Registration
- Austria EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Non-Sterile Single Use Bowmann Lacrimal Sinus Probe Diam 1.3/1.4mm Fig. 3/4 by Beauty Teck International (Pvt) Ltd — Class I — MDD — listed in EUDAMED
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDD | B-+G075BTOB51220P | Class I | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Beauty Teck International (Pvt) Ltd
- EUDAMED SRN
- PK-MF-000009604
- Authorised Representative
- CMC Medical Devices & Drugs SL ES-AR-000000293
Sources (2)
- EUDAMED f95f92b4-60e3-4d83-9f34-7d255c32e211 61 fields · synced Oct 7, 2026
- EUDAMED 6722309d-430b-409f-8cd9-56f689e9962a 61 fields · synced May 18, 2026